Method of preparing cysteine mutants of human recombinant GM-CSF
AssigneeBolder Biotechnology, Inc.
InventorsGeorge N. Cox, III, Daniel H. Doherty
Life of this patent
Estimating the term…
Loading patent…
AssigneeBolder Biotechnology, Inc.
InventorsGeorge N. Cox, III, Daniel H. Doherty
Estimating the term…
The growth hormone supergene family comprises greater than 20 structurally related cytokines and growth factors. A general method is provided for creating site-specific, biologically active conjugates of these proteins. The method involves adding cysteine residues to non-essential regions of the proteins or substituting cysteine residues for non-essential amino acids in the proteins using site-directed mutagenesis and then covalently coupling a cysteine-reactive polymer or other type of cysteine-reactive moiety to the proteins via the added cysteine residue. Disclosed herein are preferred sites for adding cysteine residues or introducing cysteine substitutions into the proteins, and the proteins and protein derivatives produced thereby. Also disclosed are therapeutic methods for using the cysteine variants of the invention.
A method for preparing a recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) protein, wherein the GM-CSF protein is a human GM-CSF cysteine mutein comprising a mutein selected from the group consisting of a cysteine residue added preceding the first amino acid of the mature protein, a cysteine residue added following the last amino acid of the protein and a cysteine residue substituted for an amino acid selected from the group consisting of A1, A3, S5, S7, N27, T32, A33, E51, R67, S69, E93, T94, T98, Q99, T102, E123, V125, Q126, and E127;
Dependencies are inferred from the claim text.